Medtronic gains FDA nod for artificial pancreas device

09/30/2013 | Star Tribune (Minneapolis-St. Paul, Minn.)

The FDA has granted Medtronic approval for what the company says is the first artificial pancreas device that stops insulin delivery automatically when the patient's blood sugar falls to preset levels. The MiniMed 530G with Enlite system, designed for diabetes patients 16 years or older, will be available commercially in the next few weeks.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC